# Commission Regulation (EC) No 1353/2007 of 20 November 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Monensin, Lasalocid and Tylvalosin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

Annex I to Regulation (EEC) No 2377/90 is amended as follows:
(1) in point 1.2.4, the entry for ‘Acetylisovaleryltylosin’ is replaced by the following:
1.2.4.
Macrolides
For porcine species, this MRL relates to “skin and fat in natural proportions”.
Not for use in animals from which eggs are produced for human consumption.
For poultry species, this MRL relates to “skin and fat in natural proportions”.’
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Tylvalosin
Sum of tylvalosin and 3-O-acetyltylosin
Porcine
50 μg/kg
Muscle
50 μg/kg
Fat
50 μg/kg
Liver
50 μg/kg
Kidney
Poultry
50 μg/kg
Fat
50 μg/kg
Liver
(2) the following point 1.2.16 is added:
‘1.2.16.
Ionophores
For poultry species, this MRL relates to “skin and fat in natural proportions”.
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Monensin
Monensin A
Bovine
2 μg/kg
Muscle
10 μg/kg
Fat
30 μg/kg
Liver
2 μg/kg
Kidney
2 μg/kg
Milk
Lasalocid
Lasalocid A
Poultry
20 μg/kg
Muscle
100 μg/kg
Fat
100 μg/kg
Liver
50 μg/kg
Kidney
150 μg/kg
Eggs
’
(3) in point 2.4.4, the entry for ‘Lasalocid’ is deleted.

---
Source: https://www.legislation.gov.uk/eur/2007/1353/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2007-1353/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.